2018 Community Oncology Conference
CLINICAL TRACKNational Harbor 12-13 |
BUSINESS TRACKPotomac AB |
PHARMACY TRACKNational Harbor 10-11 |
ADVOCACY TRACKChesapeake D-F |
WEDNESDAY, APRIL 11 |
5:30 – 7:00 PM | Registration & President’s Reception |
THURSDAY, APRIL 12 |
6:30 – 7:30 AM | Registration & Buffet Breakfast in the Exhibit Hall | |||
7:30 – 7:55 AM | Conference Opening Day One: Welcome from the Co-Chairs
– Robert Baird, Jr., RN, MSA, CASC, Chief Executive Officer, Dayton Physicians Network |
|||
7:55 – 8:40 AM | A New FDA: Progress & Plans Scott Gottlieb, MD | Commissioner of Food & Drugs, U.S. Food Administration, U.S. Department of Health & Human Services |
|||
8:45 – 9:30 AM | CDK4/CDK6 Protein Coding in Breast Cancer
– Joyce O’Shaughnessy, MD, Baylor University Medical Center |
A Comprehensive Review of the 340B Drug Discount Program
– Aaron Vandervelde, Managing Director, Berkeley Research Group, LLC |
Advocacy University: Welcome & Agenda Review
– Miriam Atkins, MD, Augusta Oncology Associates |
|
9:45 – 10:30 AM | What it Takes: Fighting for My Life & My Love of the Game Mark Herzlich | New York Giants Linebacker, Super Bowl Champion & Cancer Survivor |
|||
10:30 – 10:55 AM | Break & Mark Herzlich Q&A/Book Signing in the Exhibit Hall | |||
11:00 – 11:45 AM | Role of Molecular Profiling in Tumors & Identifying Targets for Therapeutic Intervention in Patients with Advanced Cancers
– Joshua H. Bilenker, MD, Chief Executive Officer, Loxo Oncology |
A Practical Guide to Navigating MIPS
– Richard Kane, Senior Director, Avalere |
Opioid Risk Assessment in Cancer Patients
– Bob Twillman, PhD, Executive Director, Academy of Integrative Pain Management |
Advocacy 101: What We Stand For
– Rose Gerber, Director of Patient Advocacy & Education, Community Oncology Alliance (Moderator) |
11:50 AM – 12:35 PM | Sequencing the Therapeutic Options in the Treatment of Multiple Myeloma
– Shaji K. Kumar, MD, Professor of Medicine, Consultant, Division of Hematology, Chair, Dysproteinemia Group, Medical Director, Cancer Clinical Research Office, Mayo Clinic |
OCM Progress & Future
– Jeff Hunnicutt, Chief Operations Officer, Northwest Medical Specialties |
Community Pharmacies: Leveraging Access & Data to Impact Health Care Quality & Value
– Tripp Logan, PharmD, Partner, MedHere Today Consulting |
Advocacy in Action: Case Studies & Lessons Learned
– Rose Gerber, Director of Patient Advocacy & Education, Community Oncology Alliance -CPAN Chapter Leaders |
12:35 – 1:30 PM | Lunch & Networking in the Exhibit Hall | |||
1:35 – 2:35 PM | From Cancer to Ebola: How an Oncologist Played a Role in Helping Eradicate Ebola From Liberia
– Richard W. Childs, MD, Rear Admiral, United States Public Health Service Commissioned Corps, Assistant United States Surgeon General, Clinical Director, National Heart, Lung & Blood Institute, NIH |
PBMs: Legal Update & What You Should be Doing
– Jonathan E. Levitt, Esq., Founding Partner, Frier Levitt |
Cancer Care Politics: The View from the Capitol Hill & Beyond
– Ted Okon, MBA, Executive Director, Community Oncology Alliance |
|
2:35 – 3:20 PM | Moving the OCM 2.0 from Concept to Universal Payment Model
– Mark Fendrick, MD, Director, Value-Based Insurance Design, University of Michigan |
Leaving Your Mark: Effective Advocacy Communications – Panel
– Rachel Griffith, Senior Director, McCabe Message Partners |
||
3:20 – 3:50 PM | Networking in the Exhibit Hall | |||
3:55 – 4:40 PM | CAR-T in Community Oncology Practice
– Houston Holmes, MD, MBA, FACP, Texas Oncology |
How Community Oncology Practices Are Evolving & Thriving
– Jeffrey Vacirca, MD, FACP, Chief Executive Officer, NY Cancer & Blood Specialists, President, Community Oncology Alliance |
Securing an Increased Capture Rate on Oral Drugs
– Stacey McCullough, PharmD, Senior Vice President, Pharmacy, Tennessee Oncology |
Leaving Your Mark: Developing Your Personal Story – Workshop
– Rachel Griffith, Senior Director, McCabe Message Partners -Paul Skowronek, Senior Vice President, McCabe Message Partners |
4:40 – 5:25 PM | The Value of Community Oncology: Site of Care Cost Differences in the Age of New Cancer Therapies
– Lucio Gordan, MD, Florida Cancer Specialists & Research Institute |
|||
5:25 – 6:30 PM | Networking & Refreshments in the Exhibit Hall |
FRIDAY, APRIL 13 |
6:30 – 7:30 AM | Buffet Breakfast in the Exhibit Hall | |||
7:30 – 8:00 AM | Conference Opening Day Two: Update from the Co-Chairs
– Robert Baird, Jr., RN, MSA, CASC, Chief Executive Officer, Dayton Physicians Network |
|||
8:00 – 9:00 AM | Washington DC Update: The Latest Legislative Issues Impacting Cancer Care & Your Practice
– Sean Callinicos, Senior Vice President, Global Government Relations & Public Policy, Cardinal Health |
|||
9:00 – 9:45 AM | Employer-Focused Initiatives in Advancing Payment for Cancer Care
-Bo Gamble, Director of Strategic Practice Initiatives, Community Oncology Alliance (Moderator) |
Community Oncology 101: Key Issues Impacting Patients & Practices
– Sibel Blau, MD, Medical Director, Northwest Medical Specialties |
||
9:45 – 10:10 AM | Break & Networking in the Exhibit Hall | |||
10:15 – 11:00 AM | Latest on Lung Cancer Immunotherapy
– Melissa L. Johnson, MD, Associate Director, Lung Cancer Research, Sarah Cannon Research Institute |
How to Lobby Congress – From DC to Your Practice
– Michael Diaz, MD, Director of Patient Advocacy, Florida Cancer Specialists & Research Institute, Vice President, Community Oncology Alliance |
||
11:05 – 11:50 AM | The New World of Biosimilars: From Clinical Use to Reimbursement
– Robert M. Rifkin, MD, FACP, Medical Director, Biosimilars, McKesson Specialty Health, The US Oncology Network |
Tech Talk: IT Issues That Should Be on Your Practice Radar Screen
-Barry Russo, Chief Executive Officer, The Center for Cancer & Blood Disorders (Moderator) |
Patient Access & Reimbursement: Current Challenges & Strategies
– Chris Mancill, Vice President, Government Programs & Reimbursement, EMD Serono, Inc. |
Growing Your CPAN Chapter: Strategies for Success
– Rose Gerber, Director of Patient Advocacy & Education, Community Oncology Alliance (Moderator) |
11:50 AM – 12:50 PM | Lunch & Networking in the Exhibit Hall | |||
12:50 – 1:35 PM | Recent Advances & Ongoing Challenges in Head & Neck Cancers
– Robert I. Haddad, MD, Disease Center Leader, Head & Neck Oncology Program, Dana-Farber Cancer Institute, Associate Professor of Medicine, Harvard Medical School |
APPs & APNs: Increasing Importance to a Successful Community Practice
-Robert Baird, Jr., RN, MSA, CASC, Chief Executive Officer, Dayton Physicians Network (Moderator) |
Pharmacy Roundtable: Hot Community Oncology Practice Issues
– COPA Board Members |
Looking Ahead: Planning for 2018 & Beyond
(Closed Session: CPAN Scholarship Recipients Only) |
1:40 – 2:25 PM | Integrating Palliative Care in Oncology Practice: Building Better Bridges to Quality of Life
– Rebecca A. Kirch, JD, Executive Vice President, Healthcare Quality & Value, National Patient Advocate Foundation |
Preventing Physician Burnout: Curing the Chaos & Returning Joy to the Practice of Medicine
– Byron C. Scott, MD, MBA, Deputy Chief Health Officer, Simpler Consulting, IBM Watson Health |
Advocacy University: Wrap Up & Next Steps
– Rose Gerber, Director of Patient Advocacy & Education, Community Oncology Alliance |
|
2:30 – 2:50 PM | Conference Wrap-up: Meeting Observation from the Co-Chairs & Audience |